PCPH was initially identified as a proto-oncogene in the PI's laboratory on the basis of its frequent detection as an activated oncogene (mt-PCPH) in chemically initiated, tumorigenic Syrian hamster embryo cells. It was later shown that PCPH is highly conserved in vertebrates, and that the mt-PCPH oncogene synergized with the human H-ras oncogene in the transformation of murine NIH3T3 fibroblasts. The central objective of this continuation application is to investigate the normal PCPH function and to establish the mechanism(s) by which PCPH alterations contribute to tumor development. Results obtained during the current funding period have shown that: i) Both PCPH and mt-PCPH have a predominant intracellular location; ii) the hydrophobic C-terminal tail present in the mt-PCPH oncoprotein is a key determinant of its transforming activity; iii) expression of mt-PCPH, but not of PCPH, activates the ERK1 kinase; iv) both PCPH and mt-PCPH have intrinsic ATP diphosphohydrolase (apyrase) activity, v) mt- PCPH expression provides cell survival functions by partially depleting endogenous ATP pools to levels below those optimal for stress-induced signaling and apoptosis, and vi) expression of PCPH polypeptides is frequently deregulated in neoplastic animal and human cells. We hypothesize that PCPH is a component of the cellular ATP-sensing machinery and functions by interacting with signaling circuits in charge of balancing endogenous ATP pools and external supplies, Alterations of these interactions by either mutational activation of PCPH into an oncoprotein (mt-PCPH) or by deregulation of PCPH expression contribute to tumor development. This hypothesis will be tested by several approaches: 1) Analysis of mechanisms of transformation by mt-PCPH or deregulated expression of PCPH; 2) Study of the involvement of PCPH in regulating cellular ATP pools; 3) Analysis of PCPH/mTOR functional interactions in yeast cells; and 4) Study of the participation of PCPH in human cancer. These studies will provide a fundamental understanding of the function and regulation of wild type and oncogenic PCPH in normal and malignant cells, and may have important implications for the diagnosis and management of human tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA064472-10
Application #
6805064
Study Section
Special Emphasis Panel (ZRG1-PTHB (02))
Program Officer
Okano, Paul
Project Start
1995-04-01
Project End
2007-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
10
Fiscal Year
2004
Total Cost
$291,776
Indirect Cost
Name
Georgetown University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
MacCarthy, Caitlin M; Notario, Vicente (2013) The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family. Int J Oncol 43:1244-52
Liu, Y; Yan, S; Wondimu, A et al. (2010) Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth. Oncogene 29:3297-306
Villar, JoaquĆ­n; Quadri, Humair S; Song, Insun et al. (2009) PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization. Cancer Res 69:102-10
Becerra, S Patricia; Perez-Mediavilla, L Alberto; Weldon, John E et al. (2008) Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site. J Biol Chem 283:33310-20
Villar, Joaquin; Arenas, Maria Isabel; MacCarthy, Caitlin M et al. (2007) PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. Cancer Res 67:10859-68
Tirado, Oscar M; Mateo-Lozano, Silvia; Sanders, Sean et al. (2003) The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation. Cancer Res 63:6290-8
Soldatenkov, Viatcheslav A; Trofimova, Irina N; Rouzaut, Ana et al. (2002) Differential regulation of the response to DNA damage in Ewing's sarcoma cells by ETS1 and EWS/FLI-1. Oncogene 21:2890-5
Recio, Juan A; Paez, J Guillermo; Sanders, Sean et al. (2002) Partial depletion of intracellular ATP mediates the stress-survival function of the PCPH oncoprotein. Cancer Res 62:2690-4
Solanas, Montserrat; Escrich, Eduard; Rouzaut, Ana et al. (2002) Deregulated expression of the PCPH proto-oncogene in rat mammary tumors induced with 7,12-dimethylbenz[a]anthracene. Mol Carcinog 33:219-27
Blanquez, Maria Jose; Regadera, Javier; Marino, Javier et al. (2002) Gradual deregulation and loss of PCPH expression in the progression of human laryngeal neoplasia. Mol Carcinog 35:186-95

Showing the most recent 10 out of 20 publications